Apoptosis cells in patients with multiple sclerosis

Apoptosis cells in patients with multiple sclerosis

.

Bibliographic Details
Main Authors:	S. A. Vostryakova, V. M. Alifirova, S. A. Ivanova, Yu. Yu. Orlova
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2008-12-01
Series:	Bûlleten' Sibirskoj Mediciny
Online Access:	https://bulletin.tomsk.ru/jour/article/view/3896

Similar Items

Apoptosis cells and regulation factors in patients with multiple sclerosis
by: S. A. Vostryakova, et al.
Published: (2009-02-01)

Cognitive disturbances in patients with multiple sclerosis
by: V. M. Alifirova, et al.
Published: (2008-09-01)

The abnormality of the biochemical parameters in the peripheral blood of patients with multiple sclerosis
by: N. V. Krotenko, et al.
Published: (2008-12-01)

Association between <i>VDR</i> polymorphism and multiple sclerosis
by: S. A. Babenko, et al.
Published: (2008-12-01)

The oxidative stress is typical peculiarity by multiple sclerosis
by: N. V. Krotenko, et al.
Published: (2008-12-01)

Polymorphism of chemokine receptor gene CCR5 in multiple sclerosis patients and in healthy subjects in the Siberian region
by: Yu. Yu. Orlova, et al.
Published: (2006-09-01)

Polymorphism of a gene <i>IL12B</i> in patients with multiple sclerosis and healthy persons
by: V. M. Alifirova, et al.
Published: (2008-12-01)

Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
by: V. M. Alifirova, et al.
Published: (2010-08-01)

The features of reproductive health in women with multiple sclerosis
by: O. A. Tikhonovskaya, et al.
Published: (2017-09-01)

Clinical characteristics of multiple sclerosis in the Tomsk region
by: V M Alifirova, et al.
Published: (2012-06-01)

Comparison of MRT-research materials of brain in multiple sclerosis and lupus erythematosus
by: Yu. N. Lisitsyna, et al.
Published: (2008-12-01)

Investigation of the bone density in multiple sclerosis
by: O. S. Dranichnikova, et al.
Published: (2008-06-01)

Epidemiological characteristics of multiple sclerosis in Tomsk Region and their dynamics for last 30 years
by: V. M. Alifirova, et al.
Published: (2012-06-01)

IgG-Dependent Dismutation of Superoxide in Patients with Different Types of Multiple Sclerosis and Healthy Subjects
by: Liudmila P. Smirnova, et al.
Published: (2020-01-01)

ATYPICAL FORMS OF MULTIPLE SCLEROSIS IN THE TOMSK REGION
by: V. M. Alifirova, et al.
Published: (2013-10-01)

BIOFEEDBACK: A NEW METHOD FOR CORRECTION OF MOTOR DISORDERS IN PATIENTS WITH MULTIPLE SCLEROSIS
by: Ya. S. Pekker, et al.
Published: (2014-08-01)

Can vitamin d suppress endothelial cells apoptosis in multiple sclerosis patients?
by: Leila Dehghani, et al.
Published: (2013-01-01)

Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis
by: A. N. Boyko, et al.
Published: (2019-11-01)

Role of HDAC3 on p53 expression and apoptosis in T cells of patients with multiple sclerosis.
by: Fanglin Zhang, et al.
Published: (2011-01-01)

New possibilities of siponimod therapy in patients with secondary progressive multiple sclerosis
by: D. S. Kasatkin, et al.
Published: (2021-02-01)

PHENOTYPIC CHARACTERIZATION AND INTRACELLULAR CYTOKINES OF MEMORY T-CELLS IN MULTIPLE SCLEROSIS PATIENTS AFTER T-CELL VACCINATION
by: I. P. Ivanova, et al.
Published: (2012-05-01)

Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets
by: N. A. Totolyan, et al.
Published: (2020-10-01)

Neuritis retrobulbaris of multiple sclerosis patients
by: Yu. N. Ignatova, et al.
Published: (2009-06-01)

T–CELL VACCINE PREPARATION FOR MULTIPLE SCLEROSIS TREATMENT
by: I. P. Ivanova, et al.
Published: (2014-07-01)

Combination therapy for multiple sclerosis in children
by: N. V. Skripchenko, et al.
Published: (2016-04-01)

Cardiointervalography in patients with multiple sclerosis
by: A. R. Rakhmatullin, et al.
Published: (2016-11-01)

Psychiatric manifestations in multiple sclerosis patients and multiple sclerosis in psychiatric patient
by: Yára Dadalti Fragoso, et al.
Published: (2009-12-01)

CYTOKINES AND HERPESVIRUSES IN CHILDREN WITH MULTIPLE SCLEROSIS
by: G. F. Zheleznikova, et al.
Published: (2016-02-01)

MONITORING OF OPHTHALMOLOGICAL INDICATORS IN PATIENTS WITH MULTIPLE SCLEROSIS
by: O. M. Andryukhina, et al.
Published: (2016-02-01)

Teriflunomide in patients with multiple sclerosis
by: N. Y. Lasch, et al.
Published: (2015-12-01)

IMPROVEMENT METHODS OF DIAGNOSIS THE VISUAL ANALYSER OF PATIENTS WITH MULTIPLE SCLEROSIS
by: A. V. Kovalenko, et al.
Published: (2013-10-01)

Dimethyl fumarate: the new tableted preparation for the treatment of multiple sclerosis
by: E. V. Popova, et al.
Published: (2015-12-01)

Epilepsy in patients with multiple sclerosis: specific features of diagnosis and therapy
by: Yu. A. Belova, et al.
Published: (2015-03-01)

Adhesion molecules and proinflammatory cytokines in cerebrospinal fluid of multiple sclerosis patients
by: S. A. Yelchaninova, et al.
Published: (2009-02-01)

Binocular Vision in Patients with Multiple Sclerosis
by: Gil-Casas A, et al.
Published: (2021-02-01)

New drugs for anti-B-cell therapy of multiple sclerosis
by: A. N. Boyko, et al.
Published: (2018-04-01)

MECHANISMS OF ANTI-PROLIFERATIVE EFFECT PRODUCED BY MESENCHYMAL STEM CELLS IN PATIENTS WITH MULTIPLE SCLEROSIS
by: M. M. Zafranskaya, et al.
Published: (2014-07-01)

Disseminated leukoencephalitis and multiple sclerosis: cause and effect
by: Lobzin Y.V., et al.
Published: (2013-06-01)

Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis
by: O. V. Boyko, et al.
Published: (2019-03-01)

Natalizumab in the treatment of multiple sclerosis. Experience of the Moscow Multiple Sclerosis Center (MMSC)
by: E. V. Popova, et al.
Published: (2014-12-01)